[A dimensional approach to negative symptoms in psychiatric disorders].
Jasmina Mallet, Baptiste Pignon, Stefan Kaiser...
https://pubmed.ncbi.nlm.nih.gov/40418005/Actively Recruiting
Led by Fondation FondaMental · Updated on 2026-10-19
3000
Participants Needed
17
Research Sites
N/A
Total Duration
Researchers are investigating whether people living with severe psychiatric disorders can be grouped into more similar subgroups based on social withdrawal and anhedonia, regardless of their usual diagnosis. The study includes adolescents and adults aged 15 to 60 with conditions such as schizophrenia, first episode psychosis, bipolar disorder, recurrent or treatment-resistant major depressive disorder, or autism spectrum disorder without intellectual disability, along with healthy volunteers aged 18 to 60. The goal is to identify clinical, genetic, biological, and brain imaging characteristics associated with these subgroups and study how they evolve over time. Participants undergo deep assessments including clinical interviews, questionnaires, and cognitive tests at inclusion and one year later. They provide fasting blood samples and optional stool samples for biological analyses. They also have two brain MRI sessions within six weeks of each assessment visit. Between visits, participants use a study-provided smartphone app to complete self-questionnaires and wear a connected watch to monitor activity, sleep, and heart rate variability for one year. Environmental exposures and healthcare data may also be linked. During the study, participants attend an inclusion visit, two one-day assessment visits one year apart, and two brain MRI scans. Researchers collect extensive clinical, biological, cognitive, and imaging data to identify subgroups and track changes over time. The main measure is the proportion of participants in subgroups defined by social withdrawal and anhedonia at baseline. The study may last about 18 months, with safety monitoring procedures included, and aims to enroll 2,500 patients and 500 healthy volunteers across multiple centers in France.
CONDITIONS
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
I
Imene Ben Mohamed
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fondation FondaMental
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single visit
Participants attend an inclusion visit for eligibility confirmation, informed consent, medical history collection, and initial questionnaires.
1 visit (in-person)
Duration - Single day for assessments, MRI within 6 weeks
Participants complete clinical interviews, questionnaires, neuropsychological tests, motor and neurological exams, and give fasting blood samples. They also have a 3T brain MRI within 6 weeks of this visit.
1 full-day visit and 1 MRI visit
Duration - Single day for assessments, MRI within 6 weeks
Participants repeat baseline assessments including clinical, cognitive, blood sampling, and brain MRI to track changes over one year. Optional stool samples may also be collected.
1 full-day visit and 1 MRI visit
Duration - Approximately 12 months
Between visits, participants use a study smartphone app and wear a connected watch to record activity, sleep, heart rate, and complete questionnaires over one year.
Continuous monitoring
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jasmina Mallet, Baptiste Pignon, Stefan Kaiser...
https://pubmed.ncbi.nlm.nih.gov/40418005/Antoine Yrondi, Romain Rey, Linda Scoriels...
https://pubmed.ncbi.nlm.nih.gov/40418004/Aiste Lengvenyte, Émilie Olié, Marion Leboyer...
https://pubmed.ncbi.nlm.nih.gov/40418008/Julien Coelho, Ludovic Samalin, Antoine Yrondi...
https://pubmed.ncbi.nlm.nih.gov/40418010/Ophélia Godin, Ariel Frajerman, Aiste Lengvenyte...
https://pubmed.ncbi.nlm.nih.gov/40418011/Anton Iftimovici, Renaud Jardri, Aline Lefebvre...
https://pubmed.ncbi.nlm.nih.gov/40418007/Anouck Amestoy, Jasmina Mallet, Anton Iftimovici...
https://pubmed.ncbi.nlm.nih.gov/40418009/Boris Chaumette, Antoine Yrondi, Ophélia Godin...
https://pubmed.ncbi.nlm.nih.gov/40418003/Fondation FondaMental
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor